Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm

ConclusionsBoth treatment strategies produce equivalent and better than expected outcomes compared to historical controls for N2 NSCLC, with no differences in recurrence patterns. How these conventional therapeutic strategies will compare to those involving immunotherapy combined with surgical loco-regional disease control for N2 disease remains to be determined.
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research